Stay updated on Risankizumab vs Placebo in Hidradenitis Suppurativa Clinical Trial

Sign up to get notified when there's something new on the Risankizumab vs Placebo in Hidradenitis Suppurativa Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risankizumab vs Placebo in Hidradenitis Suppurativa Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T10:25:35.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A site-wide notice announces an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T11:22:12.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer’s site revision marker changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T13:18:36.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1, while the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T12:59:00.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    A 403 Forbidden error is shown on the page, blocking access to the study record while the site chrome remains visible.
    Difference
    20%
    Check dated 2026-09-19T19:02:04.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    The page adds an explicit NIH grant/contract note for 2019 and updates the page revision tag to v3.6.6 (replacing v3.6.5).
    Difference
    0.1%
    Check dated 2026-08-29T19:05:33.000Z thumbnail image

Stay in the know with updates to Risankizumab vs Placebo in Hidradenitis Suppurativa Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risankizumab vs Placebo in Hidradenitis Suppurativa Clinical Trial page.